514
Views
32
CrossRef citations to date
0
Altmetric
Reviews

Lymphocele: prevalence and management in gynecological malignancies

, &

References

  • Braun WE, Banowsky LH, Straffon RA et al. Lymphocysts associated with renal transplantation. Report of 15 cases and review of the literature. Am. J. Med. 57(5), 714–729 (1974).
  • Glass LL, Cockett AT. Lymphoceles: diagnosis and management in urologic patients. Urology 51(5A Suppl.), 135–140 (1998).
  • Dodd GD, Rutledge F, Wallace S. Postoperative pelvic lymphocysts. Am. J. Roentgenol. Radium. Ther. Nucl. Med. 108(2), 312–323 (1970).
  • Jensen SR, Voegeli DR, Mcdermott JC, Crummy AB, Turnipseed WD. Lymphatic disruption following abdominal aortic-surgery. Cardiovasc. Intervent. Radiol. 9(4), 199–201 (1986).
  • Levi ADO. Treatment of a retroperitoneal lymphocele after lumbar fusion surgery with intralesional povidone iodine: technical case report. Neurosurgery 45(3), 658–660 (1999).
  • Mori N. Clinical and experimental studies on the so-called lymphocyst which develops after radical hysterectomy in cancer of the uterine cervix. J. Jpn Obstet. Gynecol. Soc. 2(2), 178–203 (1955).
  • Ferguson JH, Maclure JG. Lymphocele following lymphadenectomy. Am. J. Obstet. Gynecol. 82(4), 783–& (1961).
  • Logmans A, Kruyt RH, De Bruin HG, Cox PH, Pillay M, Trimbos JB. Lymphedema and lymphocysts following lymphadenectomy may be prevented by omentoplasty: a pilot study. Gynecol. Oncol. 75(3), 323–327 (1999).
  • Gray MJ, Plentl AA, Taylor HC Jr. The lymphocyst: a complication of pelvic lymph node dissections. Am. J. Obstet. Gynecol. 75(5), 1059–1062 (1958).
  • Mann WJ, Vogel F, Patsner B, Chalas E. Management of lymphocysts after radical gynecologic surgery. Gynecol. Oncol. 33(2), 248–250 (1989).
  • Benedetti-Panici P, Maneschi F, Cutillo G et al. A randomized study comparing retroperitoneal drainage with no drainage after lymphadenectomy in gynecologic malignancies. Gynecol. Oncol. 65(3), 478–482 (1997).
  • Tam KF, Lam KW, Chan KK, Ngan HY. Natural history of pelvic lymphocysts as observed by ultrasonography after bilateral pelvic lymphadenectomy. Ultrasound Obstet. Gynecol. 32(1), 87–90 (2008).
  • Kim HY, Kim JW, Kim SH, Kim YT, Kim JH. An analysis of the risk factors and management of lymphocele after pelvic lymphadenectomy in patients with gynecologic malignancies. Cancer Res. Treat. 36(6), 377–383 (2004).
  • Achouri A, Huchon C, Bats AS, Bensaid C, Nos C, Lecuru F. Complications of lymphadenectomy for gynecologic cancer. Eur. J. Surg. Oncol. 39(1), 81–86 (2013).
  • Conte M, Panici PB, Guariglia L, Scambia G, Greggi S, Mancuso S. Pelvic lymphocele following radical para-aortic and pelvic lymphadenectomy for cervical carcinoma: incidence rate and percutaneous management. Obstet. Gynecol. 76(2), 268–271 (1990).
  • Petru E, Tamussino K, Lahousen M, Winter R, Pickel H, Haas J. Pelvic and paraaortic lymphocysts after radical surgery because of cervical and ovarian cancer. Am. J. Obstet. Gynecol. 161(4), 937–941 (1989).
  • Benedet JL, Turko M, Boyes DA, Nickerson KG, Bienkowska BT. Radical hysterectomy in the treatment of cervical cancer. Am. J. Obstet. Gynecol. 137(2), 254–262 (1980).
  • Achouri A, Huchon C, Bats AS, Bensaid C, Nos C, Lecuru F. Postoperative lymphocysts after lymphadenectomy for gynaecological malignancies: preventive techniques and prospects. Eur. J. Obstet. Gynecol. Reprod. Biol. 161(2), 125–129 (2012).
  • Vansonnenberg E, Wittich GR, Casola G et al. Lymphoceles: imaging characteristics and percutaneous management. Radiology 161(3), 593–596 (1986).
  • Spring DB, Schroeder D, Babu S, Agee R, Gooding GA. Ultrasonic evaluation of lymphocele formation after staging lymphadenectomy for prostatic carcinoma. Radiology 141(2), 479–483 (1981).
  • Terada KY, Roberts JA. Lymphoceles following second-look laparotomy for ovarian cancer. Gynecol. Oncol. 29(3), 382–384 (1988).
  • Yamamoto R, Saitoh T, Kusaka T et al. Prevention of lymphocyst formation following systematic lymphadenectomy. Jpn J. Clin. Oncol. 30(9), 397–400 (2000).
  • Franchi M, Trimbos JB, Zanaboni F et al. Randomised trial of drains versus no drains following radical hysterectomy and pelvic lymph node dissection: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG) study in 234 patients. Eur. J. Cancer 43(8), 1265–1268 (2007).
  • Catalona WJ, Kadmon D, Crane DB. Effect of mini-dose heparin on lymphocele formation following extraperitoneal pelvic lymphadenectomy. J. Urol. 123(6), 890–892 (1980).
  • Tomic R, Granfors T, Sjodin JG, Ohberg L. Lymph leakage after staging pelvic lymphadenectomy for prostatic carcinoma with and without heparin prophylaxis. Scand. J. Urol. Nephrol. 28(3), 273–275 (1994).
  • Kropfl D, Krause R, Hartung R, Pfeiffer R, Behrendt H. Subcutaneous heparin injection in the upper arm as a method of avoiding lymphoceles after lymphadenectomies in the lower part of the body. Urol. Int. 42(6), 416–423 (1987).
  • Sieber PR, Rommel FM, Agusta VE et al. Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy? J. Urol. 158(3 Pt. 1), 869–871 (1997).
  • Ghezzi F, Uccella S, Cromi A et al. Lymphoceles, lymphorrhea, and lymphedema after laparoscopic and open endometrial cancer staging. Ann. Surg. Oncol. 19(1), 259–267 (2012).
  • Querleu D, Leblanc E, Carton G, Narducci F, Ferron G, Martel P. Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patients. Am. J. Obstet. Gynecol. 195(5), 1287–1292 (2006).
  • Scholz HS, Petru E, Benedicic C, Haas J, Tamussino K, Winter R. Fibrin application for preventing lymphocysts after retroperitoneal lymphadenectomy in patients with gynecologic malignancies. Gynecol. Oncol. 84(1), 43–46 (2002).
  • Suzuki M, Ohwada M, Sato I. Pelvic lymphocysts following retroperitoneal lymphadenectomy: retroperitoneal partial “no-closure” for ovarian and endometrial cancers. J. Surg. Oncol. 68(3), 149–152 (1998).
  • Benedetti-Panici P, Maneschi F, Cutillo G. Pelvic and aortic lymphadenectomy. Surg. Clin. North Am. 81(4), 841–858 (2001).
  • Franchi M, Ghezzi F, Zanaboni F, Scarabelli C, Beretta P, Donadello N. Nonclosure of peritoneum at radical abdominal hysterectomy and pelvic node dissection: a randomized study. Obstet. Gynecol. 90(4 Pt. 1), 622–627 (1997).
  • Thome Saint Paul M, Bremond A, Rochet Y. [Absence of peritonization after pelvic cancer surgery. Results in 157 cases]. J. Gynecol. Obstet. Biol. Reprod. (Paris) 20(7), 957–960 (1991).
  • Shimotsuma M, Hagiwara A, Takahashi T, Kawata M, Shields JW. Surface structure and cell zonation in human omental milky spots. Lymphology 23(4), 207–208 (1990).
  • Fujiwara K, Kigawa J, Hasegawa K et al. Effect of simple omentoplasty and omentopexy in the prevention of complications after pelvic lymphadenectomy. Int. J. Gynecol. Cancer 13(1), 61–66 (2003).
  • Benoit L, Boichot C, Cheynel N et al. Preventing lymphedema and morbidity with an omentum flap after ilioinguinal lymph node dissection. Ann. Surg. Oncol. 12(10), 793–799 (2005).
  • Rohaizak M, Khan FJ, Jasmin JS, Mohd Latar NH, Abdullah SS. Ultracision versus electrocautery in performing modified radical mastectomy and axillary lymph node dissection for breast cancer: a prospective randomized control trial. Med. J. Malaysia 68(3), 204–207 (2013).
  • Gallotta V, Fanfani F, Rossitto C et al. A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. Am. J. Obstet. Gynecol. 203(5), 483 e481–e486 (2010).
  • Carcoforo P, Soliani G, Maestroni U et al. Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial. J. Am. Coll. Surg. 196(3), 365–369 (2003).
  • Mahmoud SA, Abdel-Elah K, Eldesoky AH, El-Awady SI. Octreotide can control lymphorrhea after axillary node dissection in mastectomy operations. Breast J. 13(1), 108–109 (2007).
  • Kim WT, Ham WS, Koo KC, Choi YD. Efficacy of octreotide for management of lymphorrhea after pelvic lymph node dissection in radical prostatectomy. Urology 76(2), 398–401 (2010).
  • Aronowitz J, Kaplan AL. The management of a pelvic lymphocele by the use of a percutaneous indwelling catheter inserted with ultrasound guidance. Gynecol. Oncol. 16(2), 292–295 (1983).
  • Kim JK, Jeong YY, Kim YH, Kim YC, Kang HK, Choi HS. Postoperative pelvic lymphocele: treatment with simple percutaneous catheter drainage. Radiology 212(2), 390–394 (1999).
  • Teruel JL, Escobar EM, Quereda C, Mayayo T, Ortuno J. A simple and safe method for management of lymphocele after renal transplantation. J. Urol. 130(6), 1058–1059 (1983).
  • Karcaaltincaba M, Akhan O. Radiologic imaging and percutaneous treatment of pelvic lymphocele. Eur. J. Radiol. 55(3), 340–354 (2005).
  • Doehn C, Fornara P, Fricke L, Jocham D. Laparoscopic fenestration of posttransplant lymphoceles. Surg. Endosc. 16(4), 690–695 (2002).
  • Iwan-Zietek I, Zietek Z, Sulikowski T et al. Minimally invasive methods for the treatment of lymphocele after kidney transplantation. Transplant. Proc. 41(8), 3073–3076 (2009).
  • Gill IS, Hodge EE, Munch LC, Goldfarb DA, Novick AC, Lucas BA. Transperitoneal marsupialization of lymphoceles: a comparison of laparoscopic and open techniques. J. Urol. 153(3 Pt 1), 706–711 (1995).
  • Melvin WS, Bumgardner GL, Davies EA, Elkhammas EA, Henry ML, Ferguson RM. The laparoscopic management of post-transplant lymphocele. A critical review. Surg. Endosc. 11(3), 245–248 (1997).
  • Lucewicz A, Wong G, Lam VW et al. Management of primary symptomatic lymphocele after kidney transplantation: a systematic review. Transplantation 92(6), 663–673 (2011).
  • Radosa MP, Diebolder H, Camara O, Mothes A, Anschuetz J, Runnebaum IB. Laparoscopic lymphocele fenestration in gynaecological cancer patients after retroperitoneal lymph node dissection as a first-line treatment option. BJOG 120(5), 628–636 (2013).
  • Meyers AM, Levine E, Myburgh JA, Goudie E. Diagnosis and management of lymphoceles after renal transplantation. Urology 10(5), 497–502 (1977).
  • Atray NK, Moore F, Zaman F et al. Post-transplant lymphocele: a single centre experience. Clin. Transplant. 18 (Suppl. 12), 46–49 (2004).
  • Kay R, Fuchs E, Barry JM. Management of postoperative pelvic lymphoceles. Urology 15(4), 345–347 (1980).
  • Lucas BA, Gill IS, Munch LC. Intraperitoneal drainage of recurrent lymphoceles using an internalized Tenckhoff catheter. J. Urol. 151(4), 970–972 (1994).
  • Jensen SR, Voegeli DR, Mcdermott JC, Crummy AB. Percutaneous management of lymphatic fluid collections. Cardiovasc. Intervent. Radiol. 9(4), 202–204 (1986).
  • White M, Mueller PR, Ferrucci JT Jr. et al. Percutaneous drainage of postoperative abdominal and pelvic lymphoceles. AJR Am. J. Roentgenol. 145(5), 1065–1069 (1985).
  • Cohan RH, Saeed M, Sussman SK et al. Percutaneous drainage of pelvic lymphatic fluid collections in the renal transplant patient. Invest. Radiol. 22(11), 864–867 (1987).
  • Pope AJ, Ormiston MC, Bogod DG. Sclerotherapy in the treatment of recurrent lymphocele. Postgrad. Med. J 58(683), 573–574 (1982).
  • Akhan O, Cekirge S, Ozmen M, Besim A. Percutaneous transcatheter ethanol sclerotherapy of postoperative pelvic lymphoceles. Cardiovasc. Intervent. Radiol. 15(4), 224–227 (1992).
  • Sawhney R, D’agostino HB, Zinck S et al. Treatment of postoperative lymphoceles with percutaneous drainage and alcohol sclerotherapy. J. Vasc. Interv. Radiol. 7(2), 241–245 (1996).
  • Zuckerman DA, Yeager TD. Percutaneous ethanol sclerotherapy of postoperative lymphoceles. AJR Am. J. Roentgenol. 169(2), 433–437 (1997).
  • Kuzuhara K, Nishimori S, Kurooka Y et al. Conservative treatment of lymphocele after renal transplantation, using 95% ethanol instillation. Transplant. Proc. 26(4), 1988–1990 (1994).
  • Gilliland JD, Spies JB, Brown SB, Yrizarry JM, Greenwood LH. Lymphoceles: percutaneous treatment with povidone-iodine sclerosis. Radiology 171(1), 227–229 (1989).
  • Montalvo BM, Yrizarry JM, Casillas VJ et al. Percutaneous sclerotherapy of lymphoceles related to renal transplantation. J. Vasc. Interv. Radiol. 7(1), 117–123 (1996).
  • Rivera M, Marcen R, Burgos J et al. Treatment of posttransplant lymphocele with povidone-iodine sclerosis: long-term follow-up. Nephron 74(2), 324–327 (1996).
  • Kerlan RK Jr, Laberge JM, Gordon RL, Ring EJ. Bleomycin sclerosis of pelvic lymphoceles. J. Vasc. Interv. Radiol. 8(5), 885–887 (1997).
  • Khorram O, Stern JL. Bleomycin sclerotherapy of an intractable inguinal lymphocyst. Gynecol. Oncol. 50(2), 244–246 (1993).
  • Langle F, Schurawitzki H, Muhlbacher F et al. Treatment of lymphoceles following renal transplantation. Transplant. Proc. 22(4), 1420–1422 (1990).
  • Chin A, Ragavendra N, Hilborne L, Gritsch HA. Fibrin sealant sclerotherapy for treatment of lymphoceles following renal transplantation. J. Urol. 170(2 Pt. 1), 380–383 (2003).
  • Manfro RC, Comerlato L, Berdichevski RH et al. Nephrotoxic acute renal failure in a renal transplant patient with recurrent lymphocele treated with povidone-iodine irrigation. Am. J. Kidney Dis. 40(3), 655–657 (2002).
  • Oh SJ, Kim SH, Kim HH. Vesicolymphocele fistula following sclerotherapy for lymphocele. J. Urol. 172(6 Pt. 1), 2266 (2004).
  • Kurata H, Aoki Y, Tanaka K. Simple one-step catheter placement for the treatment of infected lymphocele. Eur. J. Obstet. Gynecol. Reprod. Biol. 106(1), 69–71 (2003).
  • Benedetti-Panici P, Maneschi F, Scambia G, Greggi S, Mancuso S. Anatomic abnormalities of the retroperitoneum encountered during aortic and pelvic lymphadenectomy. Am. J. Obstet. Gynecol. 170(1 Pt 1), 111–116 (1994).
  • McCullough CS, Soper NJ, Clayman RV, So SS, Jendrisak MD, Hanto DW. Laparoscopic drainage of a posttransplant lymphocele. Transplantation 51(3), 725–727 (1991).
  • Simonato A, Varca V, Esposito M, Venzano F, Carmignani G. The use of a surgical patch in the prevention of lymphoceles after extraperitoneal pelvic lymphadenectomy for prostate cancer: a randomized prospective pilot study. J. Urol. 182(5), 2285–2290 (2009).
  • Tinelli A, Mynbaev OA, Tsin DA, Giorda G, Malvasi A, Guido M, Nezhat FR. Lymphocele prevention after pelvic laparoscopic lymphadenectomy by a collagen patch coated with human coagulation factors: a matched case-control study. Int. J. Gynecol. Cancer 23(5), 956–963 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.